(-)-CGP-12177

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug Name(-)-CGP-12177
Drug Alias NameCGP-12177-(-)CGP-12177A(-)-CGP-12177
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonists
TargetsBeta-3 adrenergic receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A